MOBERG DERMA YEAR-END REPORT 2012
DOUBLED REVENUE, PROFITABLE AND ESTABLISHMENT IN THE U.S.FULL-YEAR (JAN-DEC 2012) · Revenue MSEK 112.5 (55.9) · Operating profit MSEK 12.6 (-7.6), MSEK 19.2 excluding acquisition-related costs · Net profit after tax MSEK 35.8 (-6.4), MSEK 42.4 excluding acquisition-related costs · Earnings per share SEK 3.68 (-0.82) · Operating cash flow per share SEK 0.97 (-0.99) · The Board proposes no dividend for the 2012 fiscal year FOURTH QUARTER (OCT-DEC 2012) · Revenue MSEK 30.2 (20.5) · Operating profit/loss MSEK -0.7 (3.8); MSEK 5.9 excluding acquisition-related